DOJ approves $69B CVS-Aetna merger with Part D divestiture

DOJ
Aetna's Part D divestiture satisfied antitrust regulators who approved the $69 billion deal with CVS Wednesday. (skpy/Flickr)

The Department of Justice (DOJ) approved a $69 billion CVS-Aetna merger on Wednesday after Aetna agreed to sell off its Part D business. 

The Part D divestiture was a condition of the merger's approval, according to the DOJ. Late last month, Aetna agreed to sell its 2.2 million Part D business to WellCare. 

RELATED: Aetna sells Part D plans to WellCare in a 'significant step' toward closing CVS deal

Free Daily Newsletter

Like this story? Subscribe to FierceHealthcare!

The healthcare sector remains in flux as policy, regulation, technology and trends shape the market. FierceHealthcare subscribers rely on our suite of newsletters as their must-read source for the latest news, analysis and data impacting their world. Sign up today to get healthcare news and updates delivered to your inbox and read on the go.